Preparation of pyrroloquinolines and related compounds as dual ATM and DNA-PK inhibitors for use in antitumor therapy

Preparation of pyrroloquinolines and related compounds as dual ATM and DNA-PK inhibitors for use in antitumor therapy

Chemical reporter probes targeting reactive cysteines in proteomic analysis and identification of cysteine protease inhibitors in cells

Preparation of oxodihydrospirocyclobutane-pyrroloquinolinylpyridinylbenzenesulfonamide derivatives and analogs for use as dual ATM and DNA-PK inhibitors

Chitosan covalently linked with small molecule integrin antagonist for targeted delivery

Integrin antagonist conjugates for targeted delivery to cells expressing LFA-1

Chitosan covalently linked with small molecule integrin antagonist for targeted delivery

Preparation of amino acid- and dipeptide-containing integrin antagonist siRNA conjugates for targeted delivery to cells expressing LFA-1

Preparation of amino acid- and dipeptide-containing integrin antagonist siRNA conjugates for targeted delivery to cells expressing VLA-4

Preparation of dipeptide-containing integrin antagonist siRNA conjugates for targeted delivery to cells expressing αVβ3

Preparation of 4-[2-(2-carboxyethyl)-3-(6-phenoxyhexyl)phenoxy]butyric acids as leukotriene B4 inhibitors

Preparation of thiazolyl-benzimidazole derivatives as PLK1 kinase inhibitors

Preparation of N-acetyl peptide amides as neuropeptide-2 receptor (Y2R) agonists

Preparation of monoaryl aminotetralines as CRTH2 antagonists

Preparation of bi-aryl aminotetralines as CRTH2 receptor antagonists

Preparation of substituted aminotetralines as CRTH2 receptor antagonists

Sulfonylphenoxy-phenoxybutyric acid derivatives as leukotriene B4 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases

Leukotriene B4 inhibitors and their preparation

Preparation of benzylpiperazinylpyrimidones as inhibitors of stearoyl-CoA desaturase (SCD1).

Preparation of 1-(indazol-5-yl)ureas as diacylglycerol O-acyltransferase (DGAT) inhibitors

Preparation of oxazolecarboxamides and related compounds as diacylglycerol acyltransferase inhibitors

Phenoxybutyric acid derivatives as leukotriene B4 inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases

Preparation of diphenyldihydroimidazopyridinones which inhibit the interaction of MDM2 protein with a p53-like peptide.

Preparation of pyrazole-4-carboxamide derivatives as 11-beta-hydroxysteroid dehydrogenase form I (11-beta-HSD1) inhibitors

Preparation of 2-(benzimidazol-1-yl)thiazole-5-carboxylic acids, their amides and esters as polo-like kinase 1 (PLK1) inhibitors for the treatment of cancer

Preparation of thiazoles as inhibitors of 11β-hydroxysteroid dehydrogenase

Preparation of pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase

Protein and cDNA sequences of human, mouse and rat G protein coupled receptor GPR39 and its therapeutic uses

Pyrazolecarboxamides as hydroxysteroid dehydrogenase inhibitors and their preparation, pharmaceutical composition and use in the treatment of diabetes, obesity and metabolic syndrome

Preparation of N-arylsulfonyl piperidines as antidiabetics

Preparation of biaryloxymethylarenecarboxylic acids as antidiabetics.

Preparation of indazolone sulfonamides as 11β-hydroxysteroid dehydrogenase inhibitors

Preparation of 3-[1-(thiazol-2-ylcarbamoyl)alkyl]-substituted hydantoins as MEK1/2 inhibitors for the treatment of cancer and other disorders

A preparation of combinatorial library of 3-aryl-1H-indole-2-carboxylic acid amides

Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid

Preparation of 1,4-benzoxazepin-3-ones as inhibitors of γ-secretase for the treatment of Alzheimer’s disease

Protein and cDNA sequences of human, mouse and rat G protein-coupled receptor #115s and use thereof as a target for identifying weight modulating compounds

Preparation of dioxoimidazolidinylalkylcarboxamides as glucokinase activators for treatment of type II diabetes.

Preparation of butyryl-tyrosinyl spermine analogs which inhibit binding of etiological agent to glutamate receptor

Preparation of antisense oligodeoxyribonucleotide duplexes

Solution and solid-phase preparation of glycosidic linkage oligosaccharides

Preparation of antisense amide-linked pyranosyl oligodeoxyribonucleosides as tyrosinase inhibitors

Butyryl-tyrosinyl spermine and analogs thereof inhibiting binding of etiological agent to glutamate receptor, and methods of preparing and using same